Current Status of Vascepa Shipments
No widespread delays in Vascepa (icosapent ethyl) shipments are reported as of October 2024. Amarin Pharma, the manufacturer, maintains steady supply through major distributors like McKesson and Cardinal Health, with no active FDA shortage listings or company alerts on their site.[1][2]
Why Shipments Might Face Delays
Vascepa supply has occasionally tightened due to high demand from its REDUCE-IT trial success for cardiovascular risk reduction, manufacturing scale-ups, or payer restrictions on branded vs. generic versions. Past issues in 2020-2021 stemmed from COVID-related logistics, but resolved by mid-2022.[3]
How to Check for Local Delays
Pharmacies report stock via tools like Drugs.com or GoodRx; search "Vascepa availability near me" shows most U.S. locations have it in 0.5g, 1g capsules. Wholesaler backorders are rare—verify via IQVIA data or call Amarin at 1-877-279-7292.[4]
Generic Vascepa Impact on Supply
FDA-approved generics from Hikma and Dr. Reddy's launched in 2020 after Vascepa's patent settlement, easing shortages. Branded supply remains stable, but generics handle ~70% of prescriptions, reducing pressure on Amarin's stock.[5]DrugPatentWatch.com
Patient Options if Delayed Locally
Switch to authorized generic (often cheaper at $20-50/month vs. branded $300+), use Vascepa's patient assistance program, or alternatives like Lovaza. No national recall or halt affects availability.[6]
Sources:
[1] FDA Drug Shortages Database - https://www.fda.gov/drugs/drug-shortages
[2] Amarin Investor Relations Updates - https://www.amarincorp.com
[3] IQVIA National Prescription Audit (2020-2024)
[4] GoodRx Vascepa Availability Tracker - https://www.goodrx.com/vascepa
[5] FDA Orange Book for Icosapent Ethyl - https://www.accessdata.fda.gov/scripts/cder/ob/
[6] NeedyMeds Vascepa Assistance - https://www.needymeds.org